8 Jan 16

Schraml BU, Hildner K, Smith WA – E, Solomon B, Sahota G, Mukasa R, Cemerski S, Hatton RD, Stormo GD, Weaver CT, Russell JH, Murphy TL, Murphy KM. The AP – 1 transcription factor BATF controls TH17 differentiation. July 2009.

In this context licensed Yissum Research Development Company of the Hebrew University of Jerusalem, the technology transfer arm the University, the immuno – isolation technology TheraCell Inc. Of California in July 2009. TheraCell aim to develop and commercialize the technology for advanced regenerative medicine procedures such as spinal fusion.This is be the first time researchers succeed, a scale to spontaneously responses in animals human reactions human responses on the same painful conditions measure have created.